Fuzionaire, McMaster ink collaboration agreement on theranostics

By AuntMinnie.com staff writers

June 29, 2022 -- Fuzionaire Diagnostics and McMaster University in Hamilton, Ontario, Canada, have signed a collaborative research agreement to develop theranostic radiopharmaceuticals.

The radiopharmaceutical will be developed using Fuzionaire Dx's HetSiFA (heteroaromatic silicon-fluoride acceptors) platform and will be evaluated at McMaster's preclinical nuclear medicine facilities, according to the firm.

Fuzionaire's HetSiFA platform is compatible with fluorine-18 (F-18), which is used for PET imaging.


Copyright © 2022 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: